Ready to INDIGO: Vorasidenib Ushers in the Era of Isocitrate Dehydrogenase Inhibition in Low-Grade Glioma
DOI: 10.1016/j.ijrobp.2023.10.045 As the medical community continues its quest to enhance therapeutic efficacy for patients…
Read MoreDOI: 10.1016/j.ijrobp.2023.10.045 As the medical community continues its quest to enhance therapeutic efficacy for patients…
Read More